What is the role of the molecular adsorbent recirculating system (MARS) in the treatment of hepatorenal syndrome (HRS)?

Updated: Oct 16, 2017
  • Author: Deepika Devuni, MD; Chief Editor: BS Anand, MD  more...
  • Print

Variations of hemodialysis include the molecular adsorbent recirculating system. [9] This is a modified dialysis method that uses an albumin-containing dialysate that is recirculated and perfused online through charcoal- and anion-exchanger columns. A prospective, randomized, controlled trial showed improvement of type 1 HRS with this method, although long-term survival remained very poor, with survival of more than 1 month in only 1 of 8 patients in the treatment arm.

If transplantation is not available, hemodialysis probably will continue to be performed for patients on the waiting list.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!